ArticleFrontiers in endocrinology2025
Insulin resistance assessed by estimated glucose disposal rate is associated with all-cause and cardiovascular mortality among postmenopausal women.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between estimated glucose disposal rate and cardiovascular mortality in postmenopausal women: a national cohort study.Nutrition & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The estimated glucose disposal rate (eGDR) is a noninvasive and practical marker for assessing insulin resistance, but its association with mortality in postmenopausal women remains uncertain. Methods: A cohort of 9371 postmenopausal women from the National Health and Nutrition Examination Survey (1999-2018) was studied. Baseline eGDR was calculated, and mortality outcomes (all-cause and cardiovascular) were linked to National Death Index (NDI) records up to December 31, 2019. Multivariate Cox regression, restricted cubic splines, and subgroup analyses were employed to assess the relationships between eGDR and mortality. Results: During a median follow-up of 98 months, 2151 deaths from all causes and 679 from cardiovascular causes were documented. In the multivariable-adjusted Cox model, higher eGDR quartiles were associated with progressively lower all-cause and cardiovascular mortality. In comparison to the lowest eGDR quartile, the highest quartile showed adjusted hazard ratios of 0.765 (0.646-0.906) for all-cause mortality and 0.677 (0.498-0.921) for cardiovascular mortality. A U-shaped relationship between eGDR and all-cause mortality was identified, with an inflection point at 5.11 mg/kg/min. Subgroup analyses revealed a stronger association between eGDR and all-cause as well as cardiovascular mortality in individuals younger than 60 years. Conclusions: Among postmenopausal women, decreased eGDR, signifying higher insulin resistance, correlates with greater risks of all-cause and cardiovascular mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.